Download MendeleyCalcium Competitive Inhibition of Langerin by Thiazolopyrimidinones.
Ning, Y., Efrem, N.L., Amoussa, M., Turhan, E., Zheng, D., Lefebre, J., Ruwolt, M., Neu, U., Besch, M., Loll, B., Kurzbach, D., Kohnke, J., Nazare, M., Rademacher, C.(2025) J Med Chem 68: 24924-24934
- PubMed: 41261040
- DOI: https://doi.org/10.1021/acs.jmedchem.5c01756
- Primary Citation of Related Structures:
9HYE - PubMed Abstract:
C-Type lectins are a large family of carbohydrate-binding proteins. Langerin is a member of this family and is expressed by Langerhans cells, involved in pathogen recognition and innate immune activation, making it a target for small-molecule modulation in immunology and infectious diseases. We previously identified thiazolopyrimidinones as a series of allosteric inhibitors, but the underlying mechanism remained unclear. In this study, 43 Ca NMR demonstrated that these fragments induce Ca 2+ release from the receptor. Our ITC data suggested a competitive relationship between inhibitors and Ca 2+ , which was further validated by 19 F NMR spectroscopy showing inhibition of carbohydrate binding. Surprisingly, the fragment binding site was found to be located beneath the long loop, which supports the dynamic nature of the long loop being highly Ca 2+ dependent. Our findings provide insight into the novel Ca 2+ -competitive inhibitory mechanism of murine langerin and are the first report on such an inhibitory mechanism for a C-type lectin.
- Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna 1090, Austria.
Organizational Affiliation:
